1729 Results

People

  1. Sklar
    Sklar
  2. Vickers
    Vickers
  3. Offit
    Offit
  4. Zauber
    Zauber
  5. Shaha
    Shaha
  6. Begg
    Begg
  7. Sepkowitz
    Sepkowitz
  8. Bernstein
    Bernstein
  9. Halpern
    Halpern
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (585)
  2. Surgery (482)
  3. Survivorship Research (423)
  4. Population Sciences Research Program (404)
  5. Epidemiology and Biostatistics (296)
  6. Solid Tumor Oncology Division (265)
  7. Division of Subspecialty Medicine (228)
  8. Center for Hematologic Malignancies (162)
  9. Hematologic Malignancies, Division of (160)
  10. Biostatistics Service (146)
  1. "risk factor"
Formats
  1. Journal Article (1457)
  2. Review (134)
  3. Editorial (53)
  4. Research Letter (26)
  5. Conference Paper (23)
  6. Guidelines (18)
  7. Correspondence (14)
  8. Meeting Abstract (3)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (585)
  2. Surgery (482)
  3. Survivorship Research (423)
  4. Population Sciences Research Program (404)
  5. Epidemiology and Biostatistics (296)
  6. Solid Tumor Oncology Division (265)

More Groups

People
  1. Charles Sklar (36)
  2. Andrew Vickers (35)
  3. Ann Zauber (33)
  4. Kenneth Offit (33)
  5. Ashok Shaha (32)
  6. Kent Sepkowitz (29)

More People

Years
  1. 2025 (82)
  2. 2024 (175)
  3. 2023 (124)
  4. 2022 (90)
  5. 2021 (57)
  6. 2020 (83)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Cancer (62)
  3. Annals of Surgical Oncology (47)
  4. European Urology (33)
  5. JNCI: Journal of the National Cancer Institute (31)
  6. Journal of the National Comprehensive Cancer Network (29)

More Publications

Publishers
  1. Elsevier Inc. (250)
  2. Springer (140)
  3. Wiley Blackwell (129)
  4. Oxford University Press (123)
  5. Elsevier Science, Inc. (119)
  6. Lippincott Williams & Wilkins (101)

More Publishers

Results (1729)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiation dose-volume-response relationships for adverse events in childhood cancer survivors: Introduction to the scientific issues in PENTEC
    Review

    Bentzen, S. M.; Vogelius, I. R.; Hodgson, D.; Howell, R.; Jackson, A.; Hua, C. H.; Olch, A. J.; Ronckers, C.; Kremer, L.; Milano, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer
    Review

    Brower, B.; McCoy, A.; Ahmad, H.; Eitman, C.; Bowman, I. A.; Rembisz, J.; Milowsky, M. I.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Embolic strokes of undetermined source: A clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC
    Guidelines

    Ntaios, G.; Baumgartner, H.; Doehner, W.; Donal, E.; Edvardsen, T.; Healey, J. S.; Iung, B.; Kamel, H.; Kasner, S. E.; Korompoki, E.; more...
    European Heart Journal (2024)

    Fulltext@MSK | Save
  • Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: Results from CALGB 89803 (Alliance)
    Journal Article

    Nakasone, E. S.; Zemla, T. J.; Yu, M.; Lin, S. Y.; Ou, F. S.; Carter, K.; Innocenti, F.; Saltz, L.; Grady, W. M.; Cohen, S. A.
    Epigenetics (2024)

    Fulltext@MSK | Save
  • Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
    Research Letter

    Saliby, R. M.; Labaki, C.; Jammihal, T. R.; Xie, W.; Sun, M.; Shah, V.; Saad, E.; Kane, M. H.; Kashima, S.; Sadak, K.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Leveraging archival cerebrospinal fluid samples for genetic insights from cell-free DNA
    Editorial

    Miller, A. M.; Bale, T. A.
    Cancer Cytopathology (2024)

    Fulltext@MSK | Save
  • Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients
    Review

    Ranjan, S.; Leung, D.; Ghiaseddin, A. P.; Taylor, J. W.; Lobbous, M.; Dhawan, A.; Budhu, J. A.; Coffee, E.; Melnick, K.; Chowdhary, S. A.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Cancer and arterial thrombosis: Therapeutic options
    Review

    Cheong, M. A.; Leader, A.
    Research and Practice in Thrombosis and Haemostasis (2024)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: A phase Ib/II study
    Journal Article

    Flowers, C. R.; Matasar, M. J.; Herrera, A. F.; Hertzberg, M.; Assouline, S.; Demeter, J.; McMillan, A.; Mehta, A.; Opat, S.; Trněný, M.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries
    Journal Article

    Nelson, A. T.; Harris, A. K.; Watson, D.; Kamihara, J.; Chen, K. S.; Stall, J. N.; Devins, K. M.; Young, R. H.; Olson, D. R.; Mallinger, P. H. R.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save